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Abstract

Background: Living with end-stage renal disease can be a daunting experience for the
individual; it takes a toll on the caregivers and affects the family dynamics. Patients are
predisposed to numerous health comorbidities, resulting in polypharmacy to treat those
conditions. Adherence to phosphate binder remains highly important to prevent a high serum
phosphate level in patients receiving hemodialysis. According to the American Kidney Fund
survey (2018), 75% of patients with end-stage renal disease reported skipping or missing at least
one pill or a dose of medicine within the past week. A collaborative conversational style such as
motivational interviewing has been found to be very effective at improving medication
adherence and cultivating change across a wide range of health behaviors.
Methods: The Plan-Do-Study-Act method of the quality improvement project was utilized for
this project. The intervention involved 60-minute face-to-face motivational interviewing (MI)
sessions held for 5 consecutive weeks during the first hour of in-center hemodialysis to assess
whether MI interventions can enhance medication adherence. Data were collected using a
self-reported medication adherence report scale 5 (MARS-5) to measure medication adherence
pre-and post-MI intervention. Higher scores indicated higher self-reported adherence, while
patients with scores less than 25 qualified to participate in the Quality Improvement project.
Results: A total of 10 patients were initially enrolled in the QI project, and two dropped out. At
the end of the intervention, eight patients completed the post-intervention MARS-5; one patient
had a 133.3% improvement and a 22.7% reduction in serum phosphate. Three patients had an
improvement in their serum phosphate levels without an improved MARS-5 score.
Conclusion: Even though short-term face-to-face MI enhanced the medication adherence rate in
only one patient, the other three patients with improved serum phosphate levels recorded high
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baseline MARS-5 scores and did not show a significant change in their MARS 5 postintervention. Several factors may predict non-adherence in this population.
In this QI study, MI improved the patient-provider rapport, increased patients' awareness
about complications associated with medication non-adherence, and demonstrated a high
tendency to improve serum phosphate levels.
Keywords: Motivational interviewing, end-stage renal disease, hemodialysis, medication
adherence, quality improvement process, hyperphosphatemia, collaborative style.
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Introduction

Patients living with end-stage renal disease face many psychological, physical, and social
challenges every day. As kidney function declines, there is a progressive deterioration of mineral
homeostasis, resulting in a disruption of their normal serum concentrations. The kidneys cannot
appropriately achieve an average serum phosphate level due to their inability to excrete the
phosphate load, resulting in hyperphosphatemia. Patients are at high risk for numerous health
comorbidities and are required to take prescribed medications, modify their diets, and undergo
dialysis to maintain homeostasis. Those requiring in center hemodialysis are expected to go to
dialysis facilities at least three times a week for hemodialysis treatment lasting up to 3 to 4 hours
each treatment. To achieve the best possible outcome, patients need to remain adherent to the
treatment regimen. Previous studies have shown associations between hyperphosphatemia and an
increased risk of fractures, cardiovascular disease, and mortality.
According to Kidney Disease: Improving Global Outcome Guidelines (2009), to maintain
a high patient survival rate, it is best to keep the serum phosphate level within the range of
3.5mg/dl to 5.0mg/dl. Pharmacologic management involves administering phosphate binders
with meals, which helps trap the phosphate in the gastrointestinal tract, preventing its absorption
(Brauer, Waheed, Singh & Maursetter, 2019). Medication non-adherence is prevalent amongst
adults with chronic illness; it can exacerbate symptoms, worsen the disease process, increase
hospitalization rates, and result in a loss of approximately $100 billion in healthcare annually
(Kini & Ho, 2018). Previous researchers have identified that individuals with the end-stage renal
disease take a minimum of 19 pills per day, thus highlighting pill burden as one of the causes
associated with medication non-adherence for this population.
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In 2018, the American Kidney Fund surveyed possible barriers to treatment adherence
amongst patients on dialysis. Results showed that 69% forget to take their medication, 75%
skipped at least a dose within the last week, and 58% reported non-adherence to a dietary
regimen. The findings were related to age, mental health status, and patient health care provider
communication. Other reports include extensive publications that revealed a prevalence of
medication non-adherence rate between 12.5% and 98.6% amongst patients on chronic
hemodialysis (Hjemas, Bovre, Mathiesen, Lindstrom & Bjerknes, 2019). Motivational
interviewing (MI), which is a collaborative conversation style that improves cognitive
dissonance between a patient's current behaviors and expected healthy goals, has been shown to
improve behavioral changes in chronic diseases by increasing patient's intrinsic motivation, thus
identifying and resolving their ambivalence (Dashtidehkordi, Shahgholian, Maghsoudi, &
Sadeghian, 2018).
This quality improvement project's objective assessed motivational interviewing's
effectiveness in improving medication adherence amongst patients receiving in-center
hemodialysis. A 10-day reflective practice review was done in an outpatient dialysis facility to
identify a clinical need in the practice setting. Findings revealed hyperphosphatemia as the
highest occurring clinical diagnosis attributed to non-medication adherence in 40% of the
patients. Predicting an improvement in patients' motivation suggests that the medication
adherence rate will increase, potentially decreasing poor health outcomes. This positive change
may lead to behavioral changes in other areas of this care plan. Also, dissemination of this QI
project may serve as a benchmark for other providers who seek to enhance patients' motivation.
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Problem Description

In patients with end-stage renal disease, hyperphosphatemia has been identified as a
common complication with an increased risk of cardiovascular mortality. Therapeutic
management with phosphate binders remains the mainstay of treatment combined with a low
phosphorus diet, yet these are often insufficient (Brauer et al., 2019). Adherence to phosphate
binder treatment remains crucial to prevent high phosphorus levels. Medication non-adherence is
prevalent amongst patients with chronic diseases and results in a 33% to 69% increase in
medication-related hospitalizations (Salvo & Cannon-Breland, 2015).
To identify the practice problem, all adult patients ages 18 years old to 95 years old
diagnosed with end-stage renal disease receiving hemodialysis were followed up for 10 days
during hemodialysis treatment. During the 10-day reflective practice review, a total of 135
patients were assessed for new complaints and existing chronic complaints, diagnosed,
laboratory results reviewed with patients, and medications prescribed. At the end of this review,
54 patients presented with high serum phosphate levels; other diagnoses encountered with an
increased number of reoccurrences were chronic hypertensive disease (10), anemia of chronic
disease (13), hyperparathyroidism of renal origin (8), hypocalcemia (11), and volume overload
(4). There were 54 patients with hyperphosphatemia, 36 males and 18 females. I was puzzled at
the high number of patients with high phosphate levels despite hemodialysis treatment, dietary
management, and use of therapeutics. The next step was to identify some of the causes of
hyperphosphatemia in patients; determining the cause will help understand patients' perspectives
and predicting factors for medication non-adherence. To do this, patients with the highest
number of hyperphosphatemia were interviewed. These were some of the reasons given: Forget
to take pills and skip medications within the past week (18), consume high phosphorus meals (4),

Quality Improvement Project

7

medicine doesn’t make me feel better (2), no specific reason given (11), and new patient yet to
commence phosphorus binders (1). Patients with no various reasons included lack of
accessibility, family support, and insurance issues.
The next step was to generate ideas. To do this, the local problem was outlined, and a
literature search was conducted to assess available knowledge and relevant studies about the lack
of medication adherence in patients with end-stage renal disease on hemodialysis. The clinical
setting and patient distribution were significant factors that I considered while developing my
PICOT question for this population. Even though only the patients with the highest frequency of
hyperphosphatemia were interviewed to find out reasons for non-adherence, this quality
improvement project focused on both male and female genders. Given these findings, the quality
improvement study question was developed as follows:
P: Adult patients ages 18 to 95 years diagnosed with end-stage renal disease and on hemodialysis
I: Motivational Interviewing
C: Unstructured provider education
O: Improved adherence to phosphate - binder medications
T: Within 5 weeks
Project Framework
The Academic Center Evidence-Based Practice (ACE) Star Model of Knowledge
Transformation (Stevens, 2013) was adapted to search and rate evidence related to the
background problem, intervention, comparison/ current practice, outcome, and timing, also
known as PICOT question, which was applied to this quality improvement project. The premise
is the vast need to research evidence-based articles that have shown promising strategies at
mitigating the complexities and challenges related to the lack of medication adherence in patients
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living with end-stage renal diseases and on hemodialysis. This model provides the appropriate
framework with which to organize and translate the evidence gathered into clinical practice.

Figure 1. ACE Star Model of Knowledge Transformation (Stevens, 2013)

Translation Method
This project is a quality improvement project geared towards developing an intervention
to improve medication adherence in patients diagnosed with end-stage renal disease receiving
hemodialysis. Reflective practice was completed on 135 patients to identify background
problems. The ACE Star Model includes a five-point star, as seen in Figure 1.
A robust literature search was conducted to discover and acquaint myself with
information and available knowledge to improve medication adherence in chronic diseases and
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hemodialysis to initiate the translation. During the initiation process, knowledge was derived
through research evidence, systematic reviews, colleagues' experiences, patient preference, and
theoretical principles. Pieces of evidence obtained were classified into their levels of hierarchy,
and some of the articles with the most influential group of proof that supported face-to-face
motivational interviewing in improving medication adherence were extracted, critiqued,
summarized, and presented to the project review team as a proposal and then approved for
implementation.
The research findings helped to assess consistencies and inconsistencies across the
studies. They guided the choice of intervention on the use of cognitive-behavioral strategy at
improving medication adherence in hemodialysis. Furthermore, face-to-face motivational
interviewing was conducted amongst eight patients during the first hour of hemodialysis
treatment for 5 weeks. Before implementing motivational interviewing, medication adherence
was measured using the self-reported Medication Adherence Report Scale (MARS-5); this is one
of the simplest and best ways that has been validated for obtaining self-adherence reports from
patients. One of the limitations, though, is that it is subjective.
Results
Effects of MI were evaluated post-intervention using the MARS-5. It revealed a 133.3%
improvement in MARS-5 for one patient. The secondary outcome was an average of 22.6%
reduction in serum phosphate levels for four patients. There was no significant improvement in
the medication adherence report score for seven patients.
Impact
Motivational Interviewing is a powerful collaborative style that can play a significant role
in resolving ambivalence. This improves behavioral changes and allows the practitioner to
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understand the patient's perspective and, together with the patient, strategize and plan care
tailored to individual needs. In this case, MI was short-term and improved medication adherence,
but the patients need to be followed up for a longer time to help translate that change into a habit.

Available Knowledge
Search Strategies
A literature review was conducted in electronic databases and reference lists on relevant
articles that assessed different interventions that may be appropriate to improve medication
adherence amongst adults living with chronic disease or end-stage renal disease.
Databases such as Cochrane, PubMed, Embase, CINAHL, and Google Scholar were searched
using keywords such as adherence to medication, nurse-led, nurse practitioner, end-stage renal
disease, strategies to improve medication adherence medications, providers, dialysis providers,
nephrologists, patients' perspectives, end-stage kidney disease, end-stage renal disease, chronic
kidney disease, kidney diseases, interviews, health education, and these resulted in 334 articles.
Further search focused on systematic reviews from 2015-2020 and the use of OR instead of
AND to streamline the search results to 25 articles. I also looked at articles that were
significantly related and relevant to the topic whereby the studies were done. The validity,
reliability, applicability, strength, and weakness of these articles were considered, and they had
to meet the criteria for preferred reporting items for systematic reviews and meta-analysis
criteria, narrowing it down to six articles used for this quality improvement study. Also, few
studies that were of moderate level of evidence were reviewed because of their significance to
the quality improvement project.
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Literature Review
End-stage renal disease is plagued with complex treatments that require patient
engagement to improve morbidity and mortality rates. Life-altering therapies, such as
hemodialysis and pharmacology management, require patient-centered care and commitment.
Dealing with medication non-adherence in end-stage renal disease can be challenging because
the phosphate binder is the mainstay for the therapeutic management of serum phosphate level.
Due to the high pill burden found in chronically ill patients, in combination with other predicting
factors, patients are faced with polypharmacy, resulting in medication non-adherence. In the
U.S., poor adherence has accounted for 33% to 69% of hospitalizations yearly, costing up to
$100 billion (Obrero Churillo, 2012). Medication non-adherence can be intentional or
unintentional; nevertheless, the outcome is a significant problem that prevents a desirable result
in this population. This increases the hospitalization rate, which may lead to increased mortality
and costs. Extensive research has shown the effectiveness of motivational interviewing to
improve many chronic disease problems by motivating behavior changes, such as smoking,
human immunodeficiency virus HIV), and other chronic diseases. According to Murthy,
Choudhury, Shakila, and Sethuraman (2016), patient-centered care encourages a shared
consultation between the provider and patient, hence, guides the decision about the plan of care.
A systematic review of randomized trials by Palacio, Garay, Langer, Taylor, Wood &
Tamariz (2016), evaluated the impact of MI on medication adherence. Seventeen synthesized
quantitative studies examined how the delivery format, counselor background, MI exposure, and
MI exposure time can improve medication adherence. The intervention lasted about 3 months or
less on eight of those studies and 9 months to 12 months on nine of them. The different MI
delivery formats used were face-to-face on eight studies; three were group, three were over the
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phone, and three were mixed formats. The frequency was between 1 week apart to 12 weeks
apart for studies with more extended intervention periods. Most of the studies reported MI
encounters lasting between 45 to 60 minutes, even though in 11 studies, MI duration ranged from
30 minutes to 2 hours. Other resources such as videos, audiotapes, calendars, and educational
materials were provided in addition to MI.
There was a combination of both objective and subjective use of medication adherence
tools. Some of the instruments were medication event monitoring systems (MEMS), pharmacy
claims data, and self-reported measuring report scales. The MI interventionists were trained for
about 4 to 40 hours, and they included three workers in the call center, nurses, health educators,
clinical psychologists, doctoral students, counselors, and pharmacists. Results showed that
phone-based and group MI improved adherence measured. MI adherence also improved when
the interviewing was conducted by nurses or research assistants with no specific degree.
Interventions with psychologists, pharmacists, or master’s-level educators showed no significant
improvement on the MI effect. Duration of exposure did not impact adherence. Even though this
study identified MI's effectiveness at improving medication adherence, it failed to present if
medication adherence was measured at baseline. Also, the use of different adherent tools may
alter the outcome. It looked like the patients did not have a known relationship with some MI
providers; in other words, it is hard to trust unfamiliar faces with personal health information.
The idea of call center workers participating in MI may not have been the best approach and may
have affected results.
Another study by Dashtidehkordi et al. (2018) examined motivational interviewing's
effect on patients' health status undergoing hemodialysis in Iran. This was a single-blind

Quality Improvement Project

13

parallel, randomized clinical trial conducted on 57 patients undergoing hemodialysis. This study
is of great importance for comparing results with previous studies, which showed that the health
status for patients undergoing hemodialysis is lacking. To maintain good health, it is required of
them to follow the prescribed treatment regimen. The researchers argued that improving their
adherence can play a vital role in improving their health. According to Dashtidehkordi et al.
(2018), a subjective baseline questionnaire was completed using the General Health
Questionnaire pre and 1-week post-intervention by patients aged 18 years to 60 years who could
speak in the native language (Farsi). Two groups, experimental and control, were assigned, with
the experimental group in cohorts of 10 for each 90-minute session of MI for 5 weeks. The
control group received group discussions about their diseases for 5 weeks. MI was conducted by
a trained researcher who used a structured guidance book. This study proved that MI could
improve the patients' general health status, especially depression, anxiety, and sleep disorders.
Zomahoun, Guenette, Gregoire, Lauzier, Moulikatou, Ferdynus, Huiart & Moisan (2017),
conducted a systematic review study to determine the effectiveness of motivational interviewing
interventions on medication adherence in adults with chronic disease. Findings revealed that MI
could be very effective when delivered face-to-face and when intervention involves only MI. The
eligibility criteria were developed using PICOS—
P: Population, I: Intervention, C: Comparison, O: Outcome, S: Study Design.
P: Patients with chronic kidney disease taking medications, I: MI intervention alone or in
combination with any approach, C: Individuals with chronic disease not receiving MI. O:
Improved medication adherence. S: Systematic Review and Meta-Analysis. Interventionists in
this study had to explicitly describe MI with reference to the works of its developers, Miller and
Rollnick. Relevant articles were selected by two authors using a five-step process. Findings
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showed that interventions based on motivational interviewing were most effective with a 95%
confidence interval (B 0.183, 95% CI = (0.004, 0.362). Face-to-face motivational interviews
were more effective (B=0.270, 95% CI= (0.041, 0.4981). Eleven out of the 16 studies reported
that MI interventions improved medication adherence only, where the remaining five identified
that MI also improved other health-related behaviors. Some of the limitations to this study were
the small sample size and a mixed mode of delivering MI.
Tao, Tao, Wang, and Bi (2020) conducted a systematic review search on eight databases
that looked at 40 Randomized Clinical Trials (RCTs), which included patients undergoing
hemodialysis, to evaluate the influence of psychosocial and educational interventions on
improving adherence for end-stage renal disease patients. Interventions included all types of
psychosocial or educational interventions (cognitive, behavioral, motivational interviewing,
relaxation, support, education, counseling, consultation, provision of resources, supervision, and
telephone hotlines). These were conducted in a group, face-to-face, written, and telephone
interviews. The outcome was an improvement in medication adherence; however, motivational
interviewing was face-to-face or telephonic. Also, the secondary outcome was an enhanced
intradialytic weight gain and achieved serum electrolytes within range. The meta-analysis results
suggest that psychosocial and educational interventions were associated with significant
medication adherence in patients receiving dialysis regimens, primarily if conducted
individually. However, it failed to mention the adherence evaluation tool used in measuring
medication adherence.
Abughosh et al. (2019) conducted a prospective study to evaluate the enhancement of
statin adherence using a motivational interviewing intervention and past adherence trajectories in
patients with suboptimal adherence. Patients qualified if they were on statin medication for at
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least 2 years. One hundred fifty-seven patients took part in this study, and administrative claims
data were used to identify non-adherent patients retrospectively. Patients with 80% or higher on
the pharmacy administrative claims data were adherent. Patients were classified into (a) rapid
decline or discontinuation, (b) gradually declining adherence over time, (c) gaps in adherence, or
(d) high or nearly perfect adherence. MI was delivered by pharmacy students trained in MI by
phone, and it was more tailored to patients' preferences because patients with a 1-year or more
adherence history were identified. The intervention took place by phone call 1 month apart; the
first call included obtaining informed consent from the patient and the index date. However, the
effect of MI was expected to happen after the first call. Patients were followed up over 6 months
to identify adherence. Information on the MI script was customized and extracted from a
literature search on MI and barriers to statin adherence. Results showed that patients who
received the MI intervention were more likely to be adherent in the 6-month follow-up. This
study did not identify the duration of MI sessions conducted, and using the pharmacy refill data
for adherence measure does not prove that the patient administered the medication.
A qualitative explorative study by Ghimire, Castelino, Jose, and Zaidi (2017) reviewed
the perspectives of hemodialysis patients on medication adherence. It was conducted in 30
hemodialysis patients aged 44-84 years at the dialysis facility. Self-reported adherence was
measured using Morisky Green Levine Scale. All patients had between four and 19 medications
daily; more than half were non-adherent (n=17). A pharmacist researcher (SG) conducted
interviews, and both the participant and interviewer were unknown to each other. There was a
reasonable response rate above 75%. All discussions were audio-recorded and lasted between 6
and 41 minutes. Results indicated that patients expressed many concerns that led to nonadherence; some were knowledge and belief about medicines, awareness, attitude towards

Quality Improvement Project

16

medication, self-efficacy, action control such as forgetting medication, and lack of family
support.
In comparing these findings with the current quality improvement project, some
similarities that exist include using: the PICOT question in developing the background problem,
the use of self-reported adherence report, the population of interest, and the primary outcome.
However, none of these studies specifically mentioned that the MI was conducted during the first
hour of in-center hemodialysis. Some of these studies did not present a post-intervention
adherence report, while some used objective and subjective adherence reports.
Finally, the primary outcome of improving medication adherence using motivational
interviewing was achieved. Timing of motivational interviewing during the first hour did not
play a significant role during this QI project.
Specific Aims
This quality improvement project was conducted to determine the effectiveness of incenter motivational interviewing during the first hour of hemodialysis at improving medication
adherence in patients diagnosed with end-stage renal disease. Secondly, it aimed to assess
whether motivational interviewing would have a resultant positive effect on the serum phosphate
levels. Both processes and outcomes were evaluated using the QI model Plan-Do-Study-Act
(PDSA) cycle.
Methods
The quality improvement study was conducted at four dialysis facilities affiliated with El
Paso Kidney Specialists between February 8, 2021, to March 20, 2021. There are three
hemodialysis shifts on Mondays, Wednesdays, and Fridays and two shifts on Tuesdays,
Thursdays, and Saturdays. The facilities hold about 10 to 30 patients for each shift, and they are
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dialyzed concurrently for 3 to 4 hours per session. Shift allocation is as follows: 4:30 a.m. to 8:00
a.m. (first shift), 8:00 a.m. to 12:00 p.m. (second shift), and 12:00 p.m. to 4.00 p.m. (third shift).
During hemodialysis treatment, these patients are seated in their separate quarters and socially
distanced as a standard precautionary measure due to their weak immune systems, especially
since the COVID pandemic came upon us. This project ran for 5 weeks. All adult (aged 18 years
to 95 years) patients diagnosed with end-stage renal disease receiving in-center hemodialysis and
English speaking were screened with the Medication Adherence Report Scale-5 in the first-week
quality improvement study to assess medication non-adherence pre-implementation of MI.
Higher scores indicate higher self-reported adherence, while patients with lower scores qualify
for the QI project. The exclusion criteria included patients who were not English speaking with
the highest score on the MARS-5. Ethical approval was obtained from The University of Texas
at El Paso Institutional Review Board who ensured compliance with the protection of human
subjects. El Paso Kidney Specialists issued a letter of approval to allow the implementation of
the project at the facilities. Verbal consent was obtained from the patients who took part in the
quality improvement project. Figure 2 shows the selection of patients.
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Eligibility Screening at nine hemodialysis centers
with 14 shifts for Mondays through Saturdays
(n= 166)






Excluded (n=126):
Non-English Speaking (n= 114)
Hospitalized (n=8)
Missed Dialysis (n=2)
Refused to participate (n=2)

Patients who met criteria and completed their
Medication Adherence Report Scale 5
(MARS-5) on the first week (n= 40)



Patients with a higher score
on MARS-5 (n=30)
Drop Out (Hospitalized n=1)

Patients with a lower score on Medication
Adherence Report Scale MARS-5.
(n= 9)


Patients that completed Medication
Adherence Report Scale 5 post
intervention
(n= 8)
Figure 2. The flow diagram of the patient selection process.

Moved from 3rd shift to
2nd shift (n=1)
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Planning the Intervention

This quality improvement project intervention was developed after a 10-day reflective
practice on 135 patients in my clinical practice settings. The findings of the review of patients
indicated hyperphosphatemia as the highest occurring diagnosis amongst this population. I was
baffled to know that, despite three times a week of dialysis, patient education by the
nephrologists, nurse practitioners, nurses, and renal dietitians, combined with therapeutic
management with phosphorus binders, many patients still had a high serum phosphate level.
To identify possible factors, barriers, and challenges leading to high serum phosphate, patients’
perspectives were sought. The best approach was to interview the patients with the highest serum
phosphate levels.
Furthermore, it was essential to collaborate with other multidisciplinary team members
such as the nephrologists, nurse practitioners from other nephrology associates, renal dietitians,
nurses who work closely with patients to evaluate their perspectives on causes of
hyperphosphatemia in this patient population and extract possible strategies that can contribute
immensely to change. My guess was correct: The majority of responses from patients and team
members focused on medication non-adherence. The patients' most common responses ranged
from and were not limited to: “I forget to take my pills at home when I eat, and my medicines are
not on me when I leave the house.” According to former U.S. Surgeon General C. Everett Koop,
"drugs don't work in patients who don't take them" (Huang et al., 2018). Previous researchers
also identified that a higher rate of comorbidities, frequent hospitalizations, polypharmacy, and
high pill burden are predictors that contribute to medication non-adherence in patients with endstage renal disease receiving hemodialysis. Once non-adherence has been identified as the
problem, my next step was to conduct a literature review to evaluate some evidence-based
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strategies to mitigate this problem. The literature, including several articles, on medication
adherence in chronic disease and medication adherence in end-stage renal disease, showed
promising findings at the use of a cognitive-based behavior strategy such as motivational
interviewing to improve medication adherence.
The project implementation lasted for 5 weeks with 4 weeks of motivational interviewing
sessions in individual face-to-face formats. The MI sessions were 1 week apart for 60 minutes
duration in the first hour of hemodialysis treatment, except week 5, which was for
90 minutes because of administration of MARS-5 post-implementation and discussion of
results.
In the first week, the clinic staff was reminded of the project and stressed that this would
not impact the usual hemodialysis procedure time. The project manager reviewed the patient
panel for the following week and administered the MARS-5. All patients were assessed using the
MARS-5, a measurement tool for eliciting patients' reports of non-adherence. The patient with
the lowest score for each shift will meet the inclusion criteria (MARS-5) calculated by summing
scores from each question (Higher scores indicate a higher rate of self-reported medication
adherence). For this QI project, the lowest score was 6, and the highest score was 25. Afterward,
the principal investigator discussed the MARS-5 results with the patients to help them
understand how they met the criteria and established rapport. At this stage, it was imperative to
assess some of the patient's behaviors, such as the patient's level of comfort at conversing with
the provider and vice versa. It is crucial to instill trust in the patient to help build confidence.
This provokes an open and sincere patient-provider conversation. The principal investigator can
understand the patient's perspective and concerns, hence, the ability to establish a collaborative
partnership with the patient. Table 1 shows the Medication Adherence Report Scale-5.
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Name: _____________________________________________ Date: _________
Time: __________

Description of MARS-5

Range (Min-Max)

1: I forgot to take my phosphate - binder medications
2: I altered the dose of my phosphate - binder medications
3: I stopped taking my phosphate - binder medications for a while
4: I missed out on a dose of my phosphate - binder medications
5: I took less phosphate- binder medications than prescribed

1 -5
1 -5
1 -5
1- 5
1–5

Scoring:
The MARS-5 is calculated by summing scores from each question (range =5-25). Higher scores
Indicate higher self-reported adherence.

1= Always, 2= Often, 3= Sometimes, 4= Rarely, 5 =Never.
Table 1. Medication Adherence Report Scale-5
The self-report scale was created by Professor Robert Horne and consists of general statements
about medicine. For this quality improvement project, these questions have been specified with
phosphate binders to suit the nature of the project.
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Description of Weekly Motivational Interviewing Sessions
Format of Session: Individual, face-to-face session. Week 1 60 minutes.
_____________________________________________________________________________
Timing

Preparation of activities and MARS -5 completion pre-intervention

__________________________________________________________________________
Nurses were reminded of the quality improvement project, and patients who met the criteria were
identified by the project manager. These patients are adults between the ages 18 to 95years who
speak English and on hemodialysis. To assess medication adherence, the MARS 5 was
discussed with patients and completed. Results of the MARS 5 was summed up and
patients who had a score lower than 25 would qualify for the study. 10 patients qualified
for the QI project, but 2 patients dropped out before the week 2 session of MI begun. A unique
identifier was assigned to the remaining 8 patients who moved to week 2.

Format of Session: Single, face-to-face session. Week 2: Engaging with the patient.
______________________________________________________________________________
Timing
Motivational Interviewing
60 minutes during the first one hour of HD
______________________________________________________________________________
Content of
Session:
Engaging: This is the most important step in MI.
Principal investigator engaged with the patients to build a
collaborative relationship. This helps boost rapport and trust.
Lack of trust breeds fear and uncertainty, if the patient needs to be
transparent, then there is a need to break this barrier.
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Format of Session: Single, face-to-face session. Week 3: Focusing on the patient’s strength
______________________________________________________________________________
Timing
Motivational Interviewing
60 minutes during the first one hour of HD
______________________________________________________________________________
Content of
Focusing: Develop and maintain the direction of discussion on medication
Session:
non-adherence and how it affects health, most significantly related to the
phosphorus binders.
Elicit patients’ ideas about the knowledge.
Recognize resistance and do not magnify it.

Open-Ended
Questions:

Assess

What is phosphate?
Types of food rich in phosphate?
How can one get too much phosphorus, and what effect does it have on
the body?
What do you know about the importance of phosphorus binders and
how do they work?
What do you understand by medication non-adherence?
What are some barriers to taking medications?
How do you take the phosphorus binders?
What are the known side effects?
How do you take your medications?
What are some challenges/barriers in taking your medications?
How do you feel about taking medications?
Individual goals for change.
Are we working in the same direction?
Is there clarity on where we are going to?
Readiness to move to the next step.
Every session was patient-centered.
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______________________________________________________________________________
Format of Session: Single, face-to-face session. Week 4
______________________________________________________________________________
Timing
Motivational Interviewing
60 minutes during the first one hour of HD
______________________________________________________________________________
Content of
Session:

Evoking: Extract individuals' own motivation for change. Exploit ideas
and feelings about how and why. Explore change.

Open-Ended
Questions:

What would be the downside if you do not make a change?
What are the costs of making a change?
What are some of the good things that may come out of a change?
How do you think this change might affect your life in the next 2-5 years?
How significant is this change for you?
What do you think will work for you?
How confident are you about making a change?
What will you be willing to try?
What small change can you make?

Assess
Explore ambivalence.
Watch out for DARN words (Desire, Ability, Reason, Need).
Elicit change talks and press on softly.
Support autonomy.
Readiness to move to the next step.
Every session was patient-centered.
A brochure for change goals in Motivational Interviewing was utilized.
(see below).
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Figure 3a. Brochure for change goals in Motivational Interviewing
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Format of Session: Single, face-to-face session. Week 5
______________________________________________________________________________
Timing
Motivational Interviewing
60 minutes during the first one hour of HD
______________________________________________________________________________
Content of
Session:

Planning: Develop a commitment to change and build an action plan.
With the patient's permission, offer recommendations and help the patient
develop a change plan that is feasible and will suit his/ her lifestyle.
What are the reasons that motivate you to make a change?
What are some benefits of change?
Find out what the next step will be?

Assess:
Motivate the patient to follow the change plan.
Reinforce patients’ values.
Offer information appropriate information to the patient.
Focus on meeting patient’s needs.
Remember to bring the best out of the patient rather than prescribing.
Keep supporting autonomy.
Every session was patient-centered.

Format of Session: Single, face-to-face session. Week 5 continuation
______________________________________________________________________________
Timing: Administration of MARS-5 Post-intervention 30 minutes during the second hour of
HD
______________________________________________________________________________
Content of
Session:

Reinforce action plan. Administration of MARS-5 and
discussion of results.

Evaluate:
Post-intervention MARS-5 improved from 6 to 14 (133%). This patient
also had a resultant direct effect of a lower serum phosphate from 7.9gdl
6.1gdl. Three patients achieved improved serum phosphate level and no
change in the MARS- 5 post-intervention.
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Study of the Intervention

To assess the impact of the intervention, the Medication Adherence Report Scale-5 was
used to measure adherence pre-and post-intervention. MARS-5 is an effective self-report
adherence tool that has been studied and validated for its reliability in assessing and eliciting
patient’s self-adherence report of medication in various clinical instances. It is a 5-item
questionnaire that not only identifies the patient’s low medication reporting scale but also the
specific types of non-adherence behaviors such as forgetting to take medications or skipping
doses. It is cost-effective, easy to complete, practical to use in the clinical setting, and meets
quality requirements to ensure accurate self-reported adherence (Chan, Horne, Hankins &
Chisari, 2020). The principal investigator followed the Standards for Quality Improvement
Reporting Excellence 2.0 Guidelines (SQUIRE) during the conduct and reporting of the quality
improvement project.
The outcome measures identified for this project were selected based on the patients'
problem needs following the 10-day reflective practice in the clinical settings. The outcome
included an improvement in the phosphate binder adherence with or without a resultant effect on
the patients’ serum phosphate levels. Motivational interviewing was conducted face-to-face
during the first hour of hemodialysis when the patients were alert; this helps get their attention to
focus more on the issue at hand. The results of the serum phosphate level were also trended to
validate if any changes were due to the intervention or not. The results showed that from the
inception of the project on February 8, 2021, to the end on March 20, 2021, serum phosphate
levels for all eight patients were redrawn, showing that four of the eight patients had an average
of 22.6% improvement in their serum phosphate levels, indicating the fact that motivational
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interviewing results in behavioral modification. The Plan-Do-Study-Act (PDSA) cycle was used
to guide the process of this QI project.

Figure 4. Plan-Do-Study-Act (PDSA) Cycle (Institute for Healthcare Improvement, 2021).

This cycle comprises three fundamental questions that evaluate the project's aim before
the implementation of a change. It addresses the objective of the proposed intervention, and it
must be specific, measurable, and can answer these three questions: (a) How good? (b) When?
and (c) For whom? It is also essential to do a feasibility check to ensure that the organization will
benefit from the quality improvement, determine the resources needed to implement it, and how
this QI project impedes the facility's smooth operation during work hours. There may be
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roadblocks if an intervention will not benefit an organization or if an organization needs to spend
so much money implementing the change. It is essential to keep in mind that outcome and
process measures have to be checked and balanced during the intervention process. Also, it is
necessary to determine how to measure the effectiveness of the intervention to know if it
produced an improvement?
Below is the process involved in the PDSA cycle.
Planning: Data collection was done by completing a 10-day reflective practice; this led to
identifying the highest occurring diagnosis of hyperphosphatemia. Furthermore, to identify
possible reasons for hyperphosphatemia, patients were interviewed. Baseline MARS-5 was
obtained from the patients to assess medication non-adherence before implementing the
intervention. Addressing the problem of high serum phosphate will promote a better quality of
life for the patients, resulting in fewer hospitalizations, fewer missed dialysis days, improved
serum phosphate within range (3.5gdl to 5.0gdl), more minor health complications, and
improved adherence to treatment and medications. These will lead to increased revenue for the
practice. The objective of the test is to improve medication adherence in patients undergoing
hemodialysis. A robust literature search was done to assess available knowledge on medication
adherence and the best promising strategies to improve compliance to generate potential
solutions. After reviewing relevant literature and evidence-based studies, the literature was
summarized and critiqued. The quality improvement proposal was presented to the school. The
proposal went through a review process and approval by the school Institutional Review Board
(IRB).
Do: Intervention was implemented on a test basis; this allows the principal investigator to
evaluate the process and re-plan if need be. For this project intervention, MI was started on
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February 8, 2021, with 10 patients selected. The MARS 5 scores and results at baseline were
documented; some of the challenges encountered were; some patients were reluctant to take part
in the project even though they had a prior notification, dialysis-related problems such as,
intradialytic hypotension, patients cramping and infiltrating, led to some delays. During the first
shift, some of the patients seen were too drowsy to complete the MARS-5 pre-implementation by
themselves and requested the principal investigator complete them. Data will be analyzed postMI implementation using MARS-5.
Study: Results were analyzed and compared to the predictions. Some of the patients attained a
serum phosphate level within range. Findings reflected anticipated predictions; however, this
step served as a time to reflect on the process (Davila, 2021). I learnt that there might not have
been any need to conduct MI during the first hour of hemodialysis.
Act: This is the time to refine change if possible and define modifications if any. The
intervention was successful with few changes—for example, the patients' MI timing should be
individualized according to the patient's chair time. The QI should focus on one dialysis facility
to give adequate time to patients. MI sessions should be at least 90 minutes each session. This QI
project has shown to be beneficial to patients but should be done in the long term, and patients
followed up on a more extended period.
Measures
The primary outcome is to improve medication adherence to phosphate binder
medications. Demographic and clinical characteristics were collected at baseline on day 1, week
1 of QI implementation. Every patient who met the criteria and consented to participate in this
QI project was considered. The medication adherence rate was measured using the self-reported
MARS-5 at baseline before QI implementation. MARS-5 is a self-reported, validated adherence
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tool that is reliable in eliciting non-adherence in patients with chronic diseases. A significant
advantage of this tool is that it is easy to read and use, quick to complete, and the instructions
were easy to follow. It is non-judgmental and designed to normalize the reporting of nonadherence, hence decreasing the likelihood of bias. Also, the responses are presented so that
patients can identify how often medications are missed or skipped instead of using a yes or no
answer. Considering that MARS- 5 addresses medication adherence within the past 1 to 2weeks.
During the study process, the ACE Star Model of Knowledge Transformation Framework
was applied during each stage, and the Plan-Do-Study-Act (PDSA) QI model was used in the
translation of theory into practice. The theoretical framework and the QI model helped organize
and examine the scientific theories within an evidence-based approach. MI was patient-centered,
and every patient who took part in this QI project was seen face-to-face and was ready to go to
the next step of MI before being introduced to it. This strategy ensured that patients were not
prematurely moved to the next step. The principal investigator also met each week with the
professional supervisor, also known as CHAIR, overseeing the processes to seek guidance on the
project process and implementation.
To identify any improvement, the MARS-5 was administered post-intervention; even
though the result does not need to correlate with an improved serum phosphate level to recognize
success, I searched the EHR database for the most recent laboratory results on the phosphate
levels. Phosphate laboratory results were compared pre-and post-intervention, and there was an
average improvement of 22.6%. The patients who moved shifts and those who missed one
session due to hospitalization could not continue with the project and did not participate in the
completion of medication adherence report scale MARS-5 post-intervention.
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Analysis

Quantitative data analysis was used to characterize the project population for this Quality
Improvement. There was only one group for intervention. One hundred thirty-five patients were
seen during the 10-day reflective practice, and out of these 135 patients, 76 were male, and 59
were female. This data was presented on a frequency distribution that revealed 54 out of 135
patients had high serum phosphate. Feasibility of the project’s measurement tool was conducted
in relation to cost, time, and reliability before the QI project. Significant variables considered
during the literature search were the dialysis facility settings and patients' chair timings. These
were discussed, reviewed, and approved by the project chair before proceeding with the project.
Data were collected pre-and post-intervention and then plotted on a run chart to show
intervention effects. MARS-5 adherence scores were collected at baseline and post-intervention
implementation. Patients were assigned a unique identifier. Below are the run charts eliciting
MARS 5 pre-and post-implementation results and a comparison of MARS 5 with serum
phosphate level pre-and post-implementation.
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MARS 5 Pre and Post Implementation
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Table 2. MARS 5 results pre-and post-implementation.
Baseline MARS-5, Serum Phosphate Pre and Post Intervention
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Table 3. Comparing the Baseline MARS- 5 with Serum phosphate level pre and post
Intervention
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Ethical Considerations

During this project, the ethical standard was observed. The QI project utilized deidentified data. Each patient was assigned a unique serial number at the start of the project,
which the principal investigator could only identify. All nursing staff and renal dieticians on duty
were duly informed of the aim of the project. The patients were not paid to take part in this QI
study. Patients' privacy was ensured by carrying out this MI interviewing as a single face-to-face
session instead of in cohorts, and mobile screens were provided in between patients at the time of
motivational interviewing sessions. There was no audio recording, and patients were not exposed
to any adverse health risk; data collected were kept in a closed file cabinet and locked with the
key secured. El Paso Kidney Specialists approved the QI study before implementation. The
University of Texas at El Paso IRB conducted a review to ensure patient protection. All
measures were taken to ensure an ethical QI project.

Results
The Quality Improvement project took part in four dialysis facilities located in the rural
areas of El Paso, Texas. The facilities hold between 10 to 30 patients who dialyze every day
concurrently. These facilities run three shifts on Mondays, Wednesdays, and Fridays and two
shifts on Tuesdays, Thursdays, and Saturdays. Nurses were able to carry out their duties with the
patients, and the QI project did not interfere with regular procedures at the facilities.
Eight patients completed a 5-week session and the MARS-5 post-implementation. The
MARS-5 self-reported adherence tool was used to measure adherence before intervention
implementation and at the end of the intervention. At baseline, though considered non-adherent,
five patients had higher MARS-5 scores greater than 10, while three patients scored 10 and
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below. The expected outcome of QI is an improved medication adherence to phosphate binder
supported by self-reports. Also, there was a secondary outcome of an improved serum phosphate
level. Patients were seen once a week, in the first hour, for motivational interviewing during
hemodialysis sessions for a duration of 60 minutes. However, these sessions were individualized,
and three MI sessions were extended for 30 minutes. Guidelines by MI developers Miller and
Rollnick (2012) were explicitly followed. At the end of the intervention, eight patients completed
the post-intervention MARS-5 self-report adherence tool. Only one patient achieved 133.3%
improvement in the MARS 5 and a 22.6% reduction in the serum phosphate level. Also, three
patients showed no improvement in their MARS-5 self-reports but significantly improved their
serum phosphate levels. This was attributed to the already high medication adherence rate
recorded at baseline before intervention implementation. Eight patients were enrolled in this QI
project; there is a need to conduct an intervention trial on a larger scale to generalize this project.
Table 4 shows the characteristics of the patients that took part in the QI.

Variables
Number (%)
___________________________________________________________________________
Age in years
22

1 (12.5%)

29 – 49

5 (62.5%)

50 – 69

0 (0%)

70 – 89

2 (25%)

Male

5 (62.5%)

Female

3 (37.5%)

Gender
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Marital status
Married

2 (25%)

Single

6 (75%)

Living with family

6 (75%)

Total number of prescribed medications
1-5

0

6-10

0

>11

6 (75%)

>20
2 (25%)
___________________________________________________________________________
Table 4. Characteristics of Patients who Participated in the Quality Improvement Study (n=8)

Patients
Sex
MARS-5 Pre MARS-5 Post
% Improved
___________________________________________________________________________
POQI 1

M

14

14

0

POQI 2

M

9

9

0

POQ 3

F

15

15

0

POQ 4

F

10

10

0

POQ 5

M

6

14

133.3

POQ 6

F

21

21

0

POQ 7

M

17

17

0

POQ 8
M
12
12
0
___________________________________________________________________________
Table 5. Comparison of Medication Adherence Report Scale-5 Pre- and Post-Intervention
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____________________________________________________________________________
Patients
MARS-5 Pre
Phosphate Pre
Phosphate Post % Decrease
____________________________________________________________________________
POQI 1

14

6.9

6.2

10.1%

POQI 2

9

8.5

12.0

41.1%

POQ 3

15

8.4

11.7

39.2%

POQ 4

10

8.4

11.2

33.3%

POQ 5

6

7.9

6.1

22.7%

POQ 6

21

6.3

4.5

28.5%

POQ 7

17

7.8

5.5

29.4%

POQ 8
12
7.8
9.5
21.7%
____________________________________________________________________________
Table 6. Comparison of Baseline MARS 5 with Serum Phosphate Level of Patients Pre- and
Post-Intervention

Description of Motivational Interviewing Session

For the intervention, eight patients who completed the MARS-5 on February 8, 2021,
during the first week, proceeded to week 2, where they engaged and connected with the principal
investigator. This is an essential phase of MI to enable a collaborative relationship.
Week 3: Focusing: During this stage, the clinical problem was discussed with great efforts to
stay on track. The objective was to assess and evaluates the patient’s knowledge of
hyperphosphatemia. However, the patients were very engaged and sometimes preferred to
discuss personal issues. MI sessions with three patients was extended for 30 minutes. One of the
patients complained of depression; it was an opportunity to have a more detailed conversation
and administer the Patient Health Questionnaire (PHQ-9); he was referred to the psychiatrist for
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moderate depression. Two patients were concerned that their living conditions predispose them
to eat more in restaurants, which may be a contributory factor for medication non-adherence.
They also shared many personal issues with the principal investigator. Patients' perspectives and
knowledge about medication adherence were sought, and ambivalence was resolved. This was
also an opportunity to reeducate patients about dietary restrictions for renal patients. One of the
patients showed resistance initially, and the meeting was suspended for a few hours. Outcome
met. All patients were ready to go to the next phase of the MI.
Week 4 Evoking: During this time, as I met with the patients, I observed their desire for change
and how they felt about it. The use of the brochure helped to extract individuals' own motivation
for change. The reason for the change and ability to persevere was identified, and patients were
encouraged. The righting reflex was avoided; it was a very relaxed and non-judgmental
atmosphere. Outcomes were met. All patients were ready to go to the next phase of MI.
Week 5 Planning: The brochure was also utilized during this stage as action plans were
developed for all the patients. These plans were individualized, and patients exhibited a
willingness to change. MI sessions ended this week, and patients were evaluated with MARS 5
post-MI intervention. The results of the MARS 5 were discussed with the patients. The results
indicated that a patient had a 133% increase with a resultant direct effect of a 22.7% reduction in
the serum phosphate level. However, the results of 3 other patients revealed an improved serum
phosphate level without an improvement on MARS 5.
For this QI project, MI effectively improved medication adherence, which was evaluated
through MARS-5 post-intervention. However, patients who did not show any changes in the
MARS-5 score also benefited from the MI; this is reflected in the serum phosphate level. This
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indicates that MI effectively modifies behaviors with or without a direct relation with the
MARS-5 post-intervention.

Discussion

Summary
This quality improvement project explored the effectiveness of motivational interviewing
during the first hour of in-center hemodialysis. A variety of predicting factors with respect to
medication non-adherence was encountered as part of the background problems that should be
resolved to enable patients to take their medications as prescribed. Some of the factors, such as
insurance-related issues whereby a patient has a very high copay for the phosphate binders and
has no access to the medication, may be inevitable and would present the patient as non-adherent
to medicine. Also, patients reporting a lack of proper communication with the healthcare
providers were labeled as non-adherent. Some patients were not satisfied and disappointed at the
providers' lack of inquiry about their experiences with the medications, such as any adverse
effects. This made patients feel less meaningful. If they are subdued under the healthcare
provider's authority, there is a lack of trust that may prevent open conversations between the
patient and provider. The practice implications help understand the high pill burden dialysis
patients face every day and become conscious of that. This will enable a conscious effort from
the nurses to advocate for the patients when necessary and the providers to talk with the patient
and collaborate to develop the best plan possible to help them achieve medication adherence.
This can be as simple as switching medications, which may require a lower dose or quantity;
subsequently, it will decrease the pill burden and increase adherence.
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Even though motivational interviewing proved effective at improving medication
adherence in one of the patients, the problem's source should be addressed to help patients
combat medication non-adherence. According to a joint publication by the Centers for Disease
Control and Prevention and National Center for Chronic Disease Prevention and Health
Promotion (2012), improved medication adherence to anti-hypertensive treatment could prevent
almost 90,000 deaths annually (as cited in Alton, March, Mallary, & Fiandt, 2015). Conducting
face-to-face motivational interviewing was one of the best approaches that helped foster rapport
with the patients. Hence, the patient was able to express their concerns and perspectives of nonadherence. Future studies should not only focus on improving medication adherence but also
determine the provider's perspectives on medication adherence and strategies available to align
them with patients' views that may be beneficial in achieving medication adherence.

Interpretation

After the QI intervention, only one patient showed a 22.7% improvement postintervention using the MARS-5 to evaluate the outcome. However, four patients achieved an
average reduction of 22.6% in their serum phosphate level, which is a secondary outcome of this
intervention. These findings correlate with findings in other studies that proved that MI improves
medication adherence. Staff members and patients find this mode of communication acceptable
and expressed from previous experience that it has worked in the past. The nephrologists were
astonished to see an improvement related to MARS-5 post-intervention. There was improved
communication between the patients and the providers. This allowed us to discuss other ways
that specific barriers such as low-income family support can be mitigated.
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There was a discussion about implementing MI sessions with patients continuously on a longer
term to achieve more stability. However, MI takes time and will need a dedicated member of the
trained healthcare provider solely for this intervention. According to Dashtidehkordi et al.
(2018), MI effectively improves patients' general health undergoing hemodialysis. Comparing
this to the current QI project, some patients had significant improvement in their serum
phosphate level post-MI implementation.

Limitations
This QI project has some limitations and barriers. First, using a subjective tool to measure
adherence, the medication adherence report scale-5 (self-reported), patients may exaggerate their
adherence. Even though the gold standard of compliance is currently thought to be direct
observation of medication or electronic adherence monitoring (medication event monitoring
system, MEMS), this is not always feasible to achieve because researchers would have to stand
and observe patients take their medication while conducting a study; also, it could be seen as
intrusive. While the use of an electronic database can provide detailed data of usage with the
electronic medication bottles, the fact remains that “opening of the medication bottle” does not
guarantee the patient administered the medication, which can be misleading for data collection
(Chan et al., 2020). Conducting the study in the early hours of the morning made it harder to
communicate and obtain relevant data from the patients who were in the first shift; they were still
battling with sleepiness. Some patients preferred I complete the MARS-5, and in this process,
they may wish to tell me what will make me happy as a provider to avoid that feeling of
disappointment that may arise with non-adherence.
Some patients already had a high adherence at baseline and may not reflect any changes
on the post-intervention MARS-5. The reflective practice identified both males and females with
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hyperphosphatemia; however, due to the dialysis facilities' settings, this QI study focused on the
male gender during the survey process of hyperphosphatemia. There have been controversies in
previous studies concerning an effective mode of delivery for motivational interviewing. Some
studies revealed that telephone MI is superior, while some showed a better outcome with face-toface MI. There needs to be an intervention trial, specifically for this population in the long term,
to determine which MI delivery mode is more effective, and timing of MI, and the duration
necessary to achieve an effective clinical outcome.
The language barrier was another limitation due to the principal investigator's inability to
communicate in any other language except English. Out of 135 patients seen during the
reflective practice, 84.4% were non-English speaking and were not included in the QI project,
resulting in a limited number of patients who took part in this QI.
It is recommended that a more detailed study on a large scale in this population be carried out
before the findings of this QI project can be generalized.
Moreover, the patients' privacy played a part in inhibiting a more relaxed atmosphere for
patients to communicate freely with the provider. For this QI project, mobile screens were
provided by dialysis facilities to ensure privacy. Future studies need to investigate trials that will
determine the best location for face-to-face MI, either during hemodialysis or while the patient is
at home.
In summary, MI has been shown to improve self-reported medication adherence in this QI
Project and achieve a lower serum phosphate level, contributing to a decreased cardiovascular
mortality risk.
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Conclusion

Adhering to the complex and long-term regimen seen with end-stage renal diseases has
been proven to be challenging. Health care behavior encompasses a complex process that
requires going beyond the prerequisite of health risk information and should include
psychological principles and client-centered communication. Improvement in patient motivation
promotes active participation with treatment plans and, more specifically, prescribed medication
plans. This paper reports a synthesis of several literature reviews with substantial evidence in
which motivational interviewing effectively improved medication adherence in patients with
end-stage renal disease receiving hemodialysis. However, to the best of my knowledge, this is
one of the first quality improvement studies that explicitly examines the use of motivational
interviewing during the first hour of hemodialysis in the center. The use of the term "in center
hemodialysis during the first hour" was strategically included to address the patient's
hemodialysis hours' settings and timing. Hemodialysis treatment lasts between 3 to 4 hours each
session. This takes a toll on patients. It is believed that patients are more alert during the first
hour of dialysis, even though there has not been recent research-based evidence to support this.
For successful communication, it is crucial to engage with the patient when they are more alert
during dialysis. Implementing a patient-centered care strategy such as motivational interviewing,
which elicits patients' own good motivation for making behavior changes, may help to achieve a
proposed primary outcome of this quality improvement. The findings showed that MI effectively
improves medication adherence and has a direct effect on identifying possible barriers. Another
essential factor considered was the mode of delivery of MI, face-to-face, against telephone calls
or text messages. According to previous studies that compared different delivery modes for MI,
face-to-face MI showed a more remarkable improvement in modifying behaviors but not
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improving medication adherence. For this QI project, patients had the opportunity to have that
dialogue and expressed some of the barriers and challenges with me. One of the patients who
would not usually talk about his problems notified me that he has been feeling depressed, and we
got a chance to discuss in detail. I administered the PHQ-9, which identified him as moderately
depressed, and I referred him to a psychiatrist. Even though this did not directly address
medication adherence, it indirectly identified patients' psychological health needs, suggesting the
effectiveness of psychosocial interventions at promoting medication adherence in end-stage renal
disease.
While the QI interventions have been shown to improve medication adherence, the
findings suggest that the patients may benefit from long-term motivational interviewing and
follow-up. Medication adherence intervention studies that focus on patients’ characteristics and
preferences and hemodialysis settings should be conducted on a long-term basis to evaluate
strategies that can lead to reliable and lasting benefits for meaningful clinical outcomes in
patients with end-stage renal disease who are on hemodialysis. The need for a validated,
objective, easy-to-use tool that can apply to the practice settings cannot be overemphasized.
These QI project types are significant to nursing practice because they offer the Doctor of
Nursing Practice -prepared (DNP) Advanced Practice Registered Nurse (APRN) the opportunity
to research, synthesize, critique robust literature reviews, and translate theories and findings into
clinical practice. It affords the DNP student the chance to practice within the scope of his/ her
education. Additionally, QI interventions improve patient care and outcomes when a clinical
problem is identified in practice, thus allows the DNP student to initiate a scholarly project.
Completing this project brings so much joy and a sense of fulfillment to the doctorly prepared
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advanced practice nurse. It ensures that APRNs are equipped with skills to identify gaps in care,
contribute to change in health care, and improve healthcare delivery.
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Introduction
Medication nonadherence is prevalent in adults
with chronic illness such as end-stage renal
disease and can lead to increased hospitalization
rates resulting in a loss of approximately $100
billion in healthcare (Kini & Ho, 2018).

Findings

Project Description
 Design

Implications to Practice

MARS 5 Pre and Post Intervention
25

Proposal and
Work Letter

20

Clinical Issue
A 10 day reflective practice conducted on 135
patients diagnosed with end stage renal disease,
identified hyperphosphatemia as the highest
occurring diagnoses. An informal query of
patients with elevated serum phosphate revealed
non adherence to phosphate binder as the most
predicting factor. Review of literature
recognized a widely used intervention,
Motivational Interviewing (MI). This
collaborative conversation style has shown
success with improving medication adherence
(Dashtidehkordi, Shahgholian, Maghsoudi & Sadeghian,
2018).

PICOT Question
P: Adult patients ages 18 to 95years
diagnosed with end- stage renal disease
and on hemodialysis
I: Motivational Interviewing
C: Unstructured provider education
O: Improved adherence to phosphatebinder medication
T: Within 5weeks

Project Goals
 Determine Motivational Interviewing
effectiveness at improving medication
adherence, mainly phosphate-binders.
 Secondarily review potential
improvement in serum phosphate
levels.

Institutional
Review Board
Work Settings
and Resources

15
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 Frameworks

5

 ACE Star Model of Knowledge
Transformation
 Plan- Do- Study- Act Model

0

POQI 1

Evaluation Strategy
 Tool selection: Medication Adherence
Rating Scale (MARS-5) is a five-item
questionnaire. (Chan, Horne, Hankins &
Chisari, 2020)

POQI 3

POQI 4

MARS 5a

 Intervention: MI 60-minute sessions
Week 1: Project introduction for patients,
MARS -5 completion prior to MI and
discussion of questionnaire results.
Week 2: Engage with the patient
Week 3: Focus on the issue requiring change
Week 4: Evoke inner motivation for change
Week 5: Plan and develop a commitment to
change. Followed by post MARS – 5
completion; questionnaire results discussed
with patients.

POQI 2
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POQI 8

MARS 5b

Eight patients completed a post-intervention
MARS-5 ; Patient # 5 had a significant
positive change, from score 6 at baseline to
14.
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Post Intervention
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 Questionnaire administered pre and post
MI.
 Scores range from 5 to 25 points. The
higher the score, the higher self-reported
adherence.

 This QI project supports the
effectiveness of MI with medication
adherence.
 Secondarily positive changes in serum
phosphate levels suggests MI may be
an important key.
 Dissemination of findings from this
QI project can be foundational for
healthcare providers who seek to
improve patient motivation.
 Positive behavioral changes may
improve other areas of
comprehensive health plans and
potentially reduce mortality and
morbidity rates.
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